Add to My Stocks
$0.95 $0 (0%) RNUGF stock closing price Sep 21, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like RENEURON GP PLC needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about RENEURON GP PLC profits and RENEURON GP PLC debt. This statement can tell if a company is running out of money while still being profitable and is useful in RENEURON GP PLC stock analysis. RENEURON GP PLC had a negative net income cash flow of $-14.36M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. RNUGF decrease in investments stood at a value of $- for the latest quarter 2018 Q2.

View and download details of RENEURON GP PLC cash flows for latest & last 40 quarters
show more
Fiscal year is Apr - Mar2018 Q22017 Q42017 Q22016 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-3.1M1.81M-
Cash From (used in) Discontinued Operations----
Other Adjustments Net3.77M3.9M2M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.09M-0.69M-0.33M-0.44M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---103.24M
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings-30.52M11.32M-72.82M
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities----4.91M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year18.67M---
Cash & Equivalents at Year End27.96M36.76M26.81M26.28M
All figures in USD. M: Millions of USD, B: Billions of USD.

RENEURON GP PLC stock price history provides insight into historical stock price fluctuations, and RENEURON GP PLC stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • RENEURON GP PLC has cash of $27.96M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the RENEURON GP PLC stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. RENEURON GP PLC lost $-9.59M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: RENEURON GP PLC used $- cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between RENEURON GP PLC and its owners and creditors and was $- till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For RENEURON GP PLC Cash Flow

Quarterly Cash Flow Statements For RENEURON GP PLC Peers

AIT THERAPEUTIC cash flow, Biomerica cash flow, IsoRay cash flow, Kitov Pharma cash flow